𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Abnormal serotonergic development in a mouse model for the Smith–Lemli–Opitz syndrome: implications for autism

✍ Scribed by H Waage-Baudet; J.M Lauder; D.B Dehart; K Kluckman; S Hiller; G.S Tint; K.K Sulik


Book ID
116551241
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
448 KB
Volume
21
Category
Article
ISSN
0736-5748

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Pathogenesis of malformations in a roden
✍ Dehart, D. B.; Lanoue, L.; Tint, G. S.; Sulik, K. K. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

The fact that Smith-Lemli-Opitz syndrome (SLOS), a syndrome comprising major malformations involving a number of organ systems, results from an abnormality in cholesterol biosynthesis, was discovered only recently. Utilizing a drug (BM 15.766) to inhibit the same step in cholesterol biosynthesis as

Absence of ventral cell populations in t
✍ Gofflot, Fran�oise; Kolf-Clauw, Martine; Clotman, Frederic; Roux, Charles; Picar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 1 views

The Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive condition involving craniofacial and central nervous system malformations with occasional holoprosencephaly (HPE). It is caused by a defect in the 7-dehydrocholesterol (7-DHC) reductase, the enzyme catalyzing the last step of cholestero

Screening for abnormal cholesterol biosy
✍ Honda, Akira; Batta, Ashok K.; Salen, Gerald; Tint, G. Stephen; Chen, Thomas S.; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

The Smith-Lemli-Opitz syndrome (SLOS) is a common condition caused by deficiency of 7-dehydrocholesterol ⌬ 7 -reductase. The syndrome can usually be diagnosed by demonstrating markedly increased plasma concentrations of the cholesterol precursor, 7-dehydrocholesterol. We describe a simple and rapid